Pharma Journalist -

Charles River announced a multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Together, Charles River and Takeda will launch multiple integrated programs…
Read More...

BioMotiv, a mission-driven pharma company part of The Harrington Project for discovery and development, and Atomwise, the leader in using artificial intelligence (AI) for small molecule…
Read More...

Coherus BioSciences, Inc. announced the Company has entered into a licensing agreement with Innovent Biologics, (Suzhou) Co., Ltd. to commercialize Innovent’s biosimilar candidate to…
Read More...

SMi Reports: Pre-Filled Syringes East Coast 2020 will feature 3 exclusive presentations dedicated to digital connectivity in the PFS industry. Building on the success of last year’s…
Read More...

SMi reports: Registration is now open for the Highly Potent Active Pharmaceutical Ingredients Conference, which will convene in London on 11th-12th May 2020. SMi Group are pleased to…
Read More...

Alnylam Pharmaceuticals announced that the Company has initiated a rolling submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lumasiran, an…
Read More...

Zymeworks Inc. announced the initiation of a Phase 2 trial evaluating ZW25 combination therapy and an agreement with Pfizer which advances the study. Zymeworks’ HER2-targeted bispecific…
Read More...

eFFECTOR Therapeutics and Pfizer Inc. announced an exclusive worldwide license and collaboration agreement to develop small-molecule inhibitors of eukaryotic initiation factor 4E…
Read More...

Eli Lilly and Company and Dermira, Inc. announced a definitive agreement for Lilly to acquire Dermira for $18.75 per share, or approximately $1.1 billion, in an all-cash transaction.…
Read More...

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on multimodal, disease-modifying therapies for neurodegenerative diseases, reported that the previously…
Read More...